Indaptus Therapeutics | 8-K: Current report
Mar 25 20:33
Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
Mar 13 20:03
Indaptus Therapeutics | 8-K: Current report
Mar 5 00:05
Indaptus Therapeutics | 8-K: Current report
Jan 23 13:00
Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Nov 7, 2023 05:05
Indaptus Therapeutics | 8-K: Current report
Nov 6, 2023 21:13
Indaptus Therapeutics | 8-K: Current report
Oct 31, 2023 21:12
Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Aug 14, 2023 20:10
Indaptus Therapeutics | 8-K: Current report
Aug 10, 2023 20:45
Indaptus Therapeutics | 8-K: Current report
May 26, 2023 04:05
Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 11, 2023 19:05
Indaptus Therapeutics | DEFA14A: Others
Apr 12, 2023 23:48
Indaptus Therapeutics | DEF 14A: Definitive proxy statements
Apr 12, 2023 20:00
Indaptus Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 25, 2023 04:10
Indaptus Therapeutics | 8-K: Current report
Mar 23, 2023 20:00
Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update
Mar 17, 2023 20:04
Indaptus Therapeutics | 8-K: Current report
Feb 14, 2023 21:15
Indaptus Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Dec 24, 2022 05:35
Indaptus Therapeutics | 8-K: Current report
Dec 24, 2022 05:30
Indaptus Therapeutics | 8-K: Indaptus Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Nov 11, 2022 05:30
No Data
No Data